Interference of EZH2 function by the small-molecule histone methyltransferases inhibitor, DZNep, is reported to increase ROS levels in acute myeloid leukemia cells like in Bmi1-deficient mice [33]. This evidence concerns the gene PRDM9 and acute myeloid leukemia.